Eye / Ear

Filters
Category
Release Form
Primary Package
Status
Dossier Type
Search

Eye / Ear

Ciprofloxacin

Eye / Ear

Drops for eye / ear

Drops for eye / ear

0.3%: 5mL, 10mL

Container, Rx, CTD
More Less

Ciprofloxacin + Dexamethasone

Eye / Ear

Ear Drops suspension Eye drops suspension

Ear Drops suspension

3.5mg/mL+1mg/mL: 7.5mL

Container, Rx, CTD
Eye drops suspension

3.5mg/mL+1mg/mL: 7.5mL

Container, Rx, CTD
More Less

Phenazone + Lidocaine

Eye / Ear

Ear drops Solution

Ear drops Solution

16g

Container, OTC, CTD
More Less

Eye / Ear Medicines Portfolio Overview

As an eye and ear disease medications distributor and manufacturer, Farmak International offers a portfolio of ophthalmic and otic medicines, together with selected ophthalmic medical devices, to pharmaceutical and institutional partners in more than 60 countries. Product availability, regulatory status and authorised indications vary by market:

  • Ophthalmic medicines. Products are formulated for eye conditions associated with infections, inflammation, and allergies. We offer Ciprofloxacin + Dexamethasone and Diclofenac ophthalmic formulations. Our medical-device portfolio also includes a combined Taurine, Dexpanthenol, and Hypromellose eye-drop formulation for ocular-surface care. For bacterial eye infections, the portfolio includes Ciprofloxacin and Moxifloxacin ophthalmic formulations, subject to locally authorised indications, and glaucoma and IOP-control medicines. Being a glaucoma medication distributor, we offer topical drugs for glaucoma and intraocular-pressure control, subject to locally authorised indications. In the catalogue, there is Brinzolamide, Brimonidine, Timolol, Latanoprost, Latanoprost + Timolol, Brimonidine + Tіmоlоl, Betaxolol, and Travoprost.
  • Dry eye lubricants and ophthalmic medical devices for ophthalmic lubrication, ocular-surface care, and the reduction of dry-eye manifestations. In this category, we offer Sodium carboxymethyl cellulose eye drops and a combined Taurine, Dexpanthenol, and Hypromellose eye-drop formulation.
  • Otic medicines in liquid drops formulations are intended for ear conditions associated with infection, inflammation, and pain, subject to locally authorised indications. Here, the portfolio includes Ciprofloxacin + Dexamethasone eye and ear formulations, and Phenazone + Lidocaine ear drops.

Ciprofloxacin drops from our portfolio contain a fluoroquinolone antibiotic, Ciprofloxacin and are formulated for ophthalmic and otic use, subject to locally authorised indications. Depending on the applicable market authorisation, these drops may be indicated for specified bacterial infections of the eye or ear. Prescribers should refer to the relevant local product information. We are also a corticosteroid eye medication supplier and offer Ciprofloxacin with Dexamethasone, combining an antibacterial active ingredient with a corticosteroid, subject to local registration and prescribing requirements.

Institutional & Procurement Use Cases

At Farmak International, we enable seamless coordination of end-to-end logistics for complex supply chains with the use of air, sea, and land transportation. Our medicines are distributed through an ear and eye disease treatment B2B channel, subject to applicable registration, importation, and distribution requirements.

We offer eye and ear medications for hospitals, including ophthalmology and ENT departments, focused on the diagnosis, medical treatment, and surgery of eye and ear diseases; as well as outpatient eye/ENT clinics; and day-care surgery centers. Based on their documented clinical profiles and authorised therapeutic uses, the products can be evaluated for possible inclusion in the drug formularies of hospital systems or national health authorities.

As an eye and ear drop manufacturer, we offer medicines for clinical pharmacy procurement with prices tailored to institutional needs, being ready to deliver large quantities of drugs, sign multi-year contracts, and ensure a consistent supply. Depending on the market and agreed distribution model, we can ship products to group purchasing organisations and distributors in bulk or deliver smaller volumes directly to retail pharmacy chains.

Formulations, Packaging & Handling

As an otic and vision treatment medications distributor, we handle diverse packaging sizes for Farmak International products. Packages can have country-specific labelling with patient information in the languages required by the destination market. Various concentrations of the active ingredients are available.

Eye-drop formulations are supplied in product-specific containers and pack sizes. Some products require a prescription, while others may be available without a prescription, depending on their classification in the relevant market. Products are packed and labeled according to strict requirements, which apply to every otic and ophthalmic medication distributor.

As a responsible and reputable eye and ear care medications supplier, we maintain controlled storage conditions for raw materials and finished products in accordance with applicable quality requirements and product-specific storage instructions. As an otic and ocular health drug supplier, we understand the importance of transportation. Our modern and secure warehouses and transport comply with Good Distribution Practices (GDP) requirements and are designed to maintain product quality and the specified storage conditions throughout the supply chain.

Quality Assurance & Regulatory Readiness

Being an NSAID anti-inflammatory eye drops distributor and manufacturer, Farmak International applies established manufacturing and quality-control processes to its eye and ear drops to meet applicable healthcare and regulatory requirements.

Our quality system is supported by national and international certifications, including GMP certification from the Ukrainian authority, EU GMP certification from the Spanish, Polish, and Croatian authorities, and WHO certification. Also, we have certification by the Saudi Food and Drug Authority (SFDA) and JIPM TPM Excellence recognition.

GMP (Good Manufacturing Practice) is a globally recognised regulation and guideline developed to ensure that pharmaceutical products, including those produced by eye and ear drop manufacturers, meet the high quality and safety standards.

Partnership for Eye / Ear Product Supply

As an ear and eye care drug products supplier, we have 3 manufacturing plants and 14 offices serving patients across more than 60 countries. That is why we can quickly meet our partners’ needs. We offer flexible distribution models designed to support supply continuity, together with institutional pricing based on the relevant market and commercial arrangements. Our partners may receive volume-based pricing for wholesale supply and tenders, depending on order volumes and agreed commercial terms. We also assist with export-licence coordination and provide the necessary regulatory dossiers and tender documentation within the parties’ agreed responsibilities.